Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Shares Issued (2020 - 2023)

Terns Pharmaceuticals (TERN) has disclosed Shares Issued for 3 consecutive years, with $142000.0 as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Shares Issued changed N/A year-over-year to $142000.0, compared with a TTM value of $162000.0 through Dec 2023, changed N/A, and an annual FY2024 reading of $623000.0, up 51.95% over the prior year.
  • Shares Issued was $142000.0 for Q4 2023 at Terns Pharmaceuticals, up from $20000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $136.4 million in Q1 2021 and bottomed at -$32000.0 in Q4 2020.
  • Average Shares Issued over 3 years is $27.3 million, with a median of $32000.0 recorded in 2020.